Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6153)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Clausen LN, Lundbo LF, Benfield T. Hepatitis C virus infection in the human immunodeficiency virus infected patient. World J Gastroenterol 2014; 20(34): 12132-12143 [PMID: 25232248 DOI: 10.3748/wjg.v20.i34.12132] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12132.htm |
| Number | Citing Articles |
| 1 |
Lucyna Budzko, Malgorzata Marcinkowska-Swojak, Paulina Jackowiak, Piotr Kozlowski, Marek Figlerowicz. Copy number variation of genes involved in the hepatitis C virus-human interactome. Scientific Reports 2016; 6(1) doi: 10.1038/srep31340
|
| 2 |
Nasheed Moqueet, Claire Infante-Rivard, Robert Platt, Jim Young, Curtis Cooper, Mark Hull, Sharon Walmsley, Marina Klein, the Investigators. Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals. International Journal of Molecular Sciences 2015; 16(12): 6496 doi: 10.3390/ijms16036496
|
| 3 |
Micaela Parra, Natalia Laufer, Julieta M. Manrique, Leandro R. Jones, Jorge Quarleri. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1728456
|
| 4 |
Anelise Fernanda Zanolla, Caroline Buss, Dimas Alexandre Kliemann, Giselle Souza Pinto, Vivian Silveira Vasques, Cristiane Valle Tovo. Relative validity of a food frequency questionnaire in patients coinfected with hepatitis C virus and human immunodeficiency virus. Revista da Sociedade Brasileira de Medicina Tropical 2017; 50(1): 117 doi: 10.1590/0037-8682-0027-2016
|
| 5 |
Jingjing Wu, Peng Huang, Haozhi Fan, Ting Tian, Xueshan Xia, Zuqiang Fu, Yan Wang, Xiangyu Ye, Ming Yue, Yun Zhang. Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis. Virology Journal 2019; 16(1) doi: 10.1186/s12985-018-1114-4
|
| 6 |
Zaki Mita Kusumaadhi, Nur Farhanah, Muchlis Achsan Udji Sofro. Risk Factors for Mortality among HIV/AIDS Patients. Diponegoro International Medical Journal 2021; 2(1): 20 doi: 10.14710/dimj.v2i1.9667
|
| 7 |
Jorge Soares, António Ferreira, André Silva-Pinto, Francisco Almeida, Carmela Piñeiro, Rosário Serrão, António Sarmento. The Influence of Antiretroviral Therapy on Hepatitis C Virus Viral Load and Liver Fibrosis in Human Immunodeficiency Virus-Coinfected Patients: An Observational Study. Intervirology 2019; 62(5-6): 182 doi: 10.1159/000503631
|
| 8 |
Márta Marschalkó, Katinka Pónyai, Sarolta Kárpáti. Sexually transmitted coinfections. HIV coinfections. Orvosi Hetilap 2015; 156(1): 4 doi: 10.1556/OH.2015.30076
|
| 9 |
Sammy Saab, Suchin Virabhak, Hélène Parisé, Scott Johnson, Alice Wang, Derek Misurski, Yuri Sanchez Gonzalez, Timothy Juday. Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States. Advances in Therapy 2016; 33(8): 1316 doi: 10.1007/s12325-016-0362-1
|
| 10 |
Joyce Anyona Sande, Suleman Verjee, Sudhir Vinayak, Farin Amersi, Munir Ghesani. Ultrasound shear wave elastography and liver fibrosis: A Prospective Multicenter Study. World Journal of Hepatology 2017; 9(1): 38-47 doi: 10.4254/wjh.v9.i1.38
|
| 11 |
T. Joseph Mattingly, Neha S. Pandit, Eberechukwu Onukwugha. Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population. Infectious Diseases and Therapy 2019; 8(2): 219 doi: 10.1007/s40121-019-0240-7
|
| 12 |
N. G. Shmagel', Konstantin V. Shmagel', L. B. Korolevskaya, E. V. Saidakova, V. A. Chereshnev. Systemic inflammation and compromised intestinal barrier during successful treatment of HIV infection. Clinical Medicine (Russian Journal) 2016; 94(1): 47 doi: 10.18821/0023-2149-2016-94-1-47-51
|
| 13 |
Hasan Afzali, Mansooreh Momen-Heravi, Asefeh Farokhzad. Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran. Hepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.30459
|
| 14 |
Montserrat Laguno, María Martínez-Rebollar, Martina Casanova, Elisa de Lazzari, Ana González-Cordón, Berta Torres, Alexy Inciarte, Lorena de la Mora, Ainoa Ugarte, Juan Ambrosioni, José Luís Blanco, Esteban Martínez, Josep Mallolas. Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients. Clinical Microbiology and Infection 2022; 28(4): 610.e1 doi: 10.1016/j.cmi.2021.08.019
|
| 15 |
Luciani F. New Scenarios in the Treatment of HIV/HCV Co-Infection. Journal of Human Virology & Retrovirology 2015; 2(4) doi: 10.15406/jhvrv.2015.02.00049
|
| 16 |
Michael G. Ison, Madeleine Heldman. Hepatic Critical Care. 2018; : 191 doi: 10.1007/978-3-319-66432-3_15
|
| 17 |
Mariano Sede, Micaela Parra, Julieta M. Manrique, Natalia Laufer, Leandro R. Jones, Jorge Quarleri. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy. Infection, Genetics and Evolution 2016; 43: 186 doi: 10.1016/j.meegid.2016.05.032
|
| 18 |
Hans Jakob Hartling, Carsten Birch, Julie C. Gaardbo, Malene Hove, Marius Trøseid, Mette Rye Clausen, Jan Gerstoft, Henrik Ullum, Susanne Dam Nielsen. T‐cell homeostasis in chronic HCV‐infected patients treated with interferon and ribavirin or an interferon‐free regimen. APMIS 2015; 123(10): 903 doi: 10.1111/apm.12429
|
| 19 |
María-Carlota Londoño, Mar Riveiro-Barciela, Adriana Ahumada, Raquel Muñoz-Gómez, Mercé Roget, María J. Devesa-Medina, Miguel Ángel Serra, Carmen A. Navascués, Carme Baliellas, Teresa Aldamiz-Echevarría, María L. Gutiérrez, Benjamín Polo-Lorduy, Isabel Carmona, Salvador Benlloch, Lucía Bonet, Javier García-Samaniego, Miguel Jiménez-Pérez, Senador Morán-Sánchez, Ángeles Castro, Manuel Delgado, Francisco Gea-Rodríguez, Ignacio Martín-Granizo, María Luisa Montes, Luís Morano, Manuel A. Castaño, Ignacio de los Santos, Montserrat Laguno, Juan Emilio Losa, Marta Montero-Alonso, Antonio Rivero, Cristina de Álvaro, Amanda Manzanares, Josep Mallolas, Guillermina Barril, Emilio González-Parra, Luisa García-Buey, Yury E. Khudyakov. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study. PLOS ONE 2019; 14(9): e0221567 doi: 10.1371/journal.pone.0221567
|
| 20 |
Massimo Pinzani. Stellate Cells in Health and Disease. 2015; : 29 doi: 10.1016/B978-0-12-800134-9.00003-8
|